ArticleMalaria journal2026
Fatal and non-fatal health outcomes of malaria among reproductive age women in Eastern Sub-Saharan Africa, from 1990 to 2023.
Article in Malaria journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMalaria is a life-threatening disease that is transmitted by the bites of infected female Anopheles mosquitoes. Women of reproductive age (WRA) are a more vulnerable group to malaria, which increases the risk of severe anemia, maternal death, and unfavorable birth outcomes. However, only limited comprehensive studies are available in the Eastern Sub-Saharan African (ESSA) region. The Global Burden of Diseases (GBD) 2023 estimates were to assess the fatal and non-fatal health outcomes of malaria among WRA in ESSA region from 1990 to 2023.
methodThe Cause of Death Ensemble Model (CODEm) modeling platform was used to estimate mortality and Years of Life Lost (YLLs) in the GBD 2023 study. Years Lived with Disability (YLDs), prevalence, and incidence of malaria disease was estimated by using Bayesian meta-regression for Disease modeling. The net change from 1990 to 2023 was evaluated by percentage change. All estimates were presented together with the 95% uncertainty intervals (95% UIs).
resultsIn 2023, the highest prevalence rate of malaria among WRA was recorded in Mozambique [19627 cases per 100,000 WRA (95% UI: 12,347, 27,601)]. However, the lowest prevalence rate was estimated in Eritrea [842 (95% UI: 450, 1430)] and Rwanda [1603 (95% UI: 587, 3180)]. Mozambique had the highest incidence rate [16076 new cases per 100,000 WRA (95% UI: 11,890, 21,714)], whereas Eritrea had the lowest rate [2267 new cases per 100,000 WRA (95% UI: 962, 4539)]. The highest rates of mortality, YLLs and Disability-Adjusted Life Years (DALYs) were estimated in Mozambique, whereas the lowest rates were recorded in Ethiopia. There were substantial reductions in the rates throughout the region in 2023 compared to 1990, except in Djibouti and Ethiopia.
conclusionThis study has revealed that there was substantial reduction in the rates of non-fatal and fatal health outcomes of malaria among WRA in the ESSA region in 2023 compared to 1990. However, the rates remain high and heterogeneous across the region. Therefore, strengthening the health service system and sustaining strong malaria control programs across the countries are crucial to end malaria epidemics by 2030.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.